不同起源神经母细胞瘤N-myc基因扩增情况研究

doi:10.3969/j.issn.1000-8535.2015.03.004

广州医药 ›› 2015, Vol. 46 ›› Issue (3): 16-18.DOI: 10.3969/j.issn.1000-8535.2015.03.004

不同起源神经母细胞瘤N-myc基因扩增情况研究

徐涛, 石军, 牛玉林

广州市妇女儿童医疗中心血液肿瘤科(广州 510180)

收稿日期:2014-11-17 出版日期:2015-05-20 发布日期:2021-11-30

A Study of the status of N-myc amplification in neuroblastoma originating from different sites

Xu Tao, Shi Jun, Niu Yulin

Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou 510623, China

Received:2014-11-17 Online:2015-05-20 Published:2021-11-30

摘要/Abstract

摘要： 目的了解不同类型神经母细胞瘤的生物学特性。方法在本研究中,对新诊断神经母细胞瘤患者的生物学特点(N-myc基因扩增)与临床特点进行了比较。结果共49例神经母细胞瘤,起源于腹膜后35例,其他14例。两个组呈现出不同的N-myc基因扩增情况(P<0.05)。结论不同临床类型的神经母细胞瘤存在有不同的生物学特性发布情况。

关键词: 神经母细胞瘤, N-myc基因扩增, 腹膜后

Abstract: Objective To investigate the biological characteristics of neuroblastomas originating from different sites. Methods Fluorescent in situ hybridization (FISH) was employed to detect the status of N-myc amplification in patients with newly diagnosed neuroblastoma originating from different sites from July 2011 to June 2013. Results A total of 49 cases of patients with newly diagnosed neuroblastoma were identified in the study, 35 cases of neuroblastoma originating from retroperitoneal site, 14 cases from other primary sites. There were significant differences in the N-myc amplification between the two groups(P<0.05). Conclusion Patients with neuroblastomas originating from extra-retroperitoneal sites might show a more favorable biological characteristics than from retroperitoneal site.

Key words: Neuroblastoma, N-myc amplification, Retroperitoneal

徐涛, 石军, 牛玉林. 不同起源神经母细胞瘤N-myc基因扩增情况研究[J]. 广州医药, 2015, 46(3): 16-18.

Xu Tao, Shi Jun, Niu Yulin. A Study of the status of N-myc amplification in neuroblastoma originating from different sites[J]. Guangzhou Medical Journal, 2015, 46(3): 16-18.

参考文献

[1] Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma[J]. Lancet,2007,369 (9579): 2106-2120.
[2] 郑兆俭.神经母细胞瘤6例报告[J]. 哈尔滨医药,1990(1):27-29.
[3] Liu YL, Miser JS, Hsu WM. Risk-directed therapy and research in neuroblastoma[J]. J Formos Med Assoc, 2014,113(12): 887-889.
[4] Shimada H,Ambros IM,Dehner LP,et al. The International Neuroblastoma Pathology Classification (the Shimada system) [J]. Cancer,1999,86(2):364-372.
[5] Joshi VV,Cantor AB,Brodeur GM,et al. Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group[J]. Cancer 1993,71(10):3173-3181.
[6] Pession A, Tonelli R. The mycn oncogene as a specific and selective drug target for peripheral and central nervous system tumors[J]. Curr Cancer Drug Targets,2005,5(4):273-283.
[7] Hossain MM, Banik NL, Ray SK.N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification[J]. Gene,2013,529(1):27-36.
[8] Zhang Z, Yu H, Huang J, et al. The TRPM6 kinase domain determines the Mg·ATP sensitivity of TRPM7/M6 heteromeric ion channels[J]. J Biol Chem,2014,289(8):5217-5227.
[9] Suita S, Tajiri T, Sera Y, et al. The characteristics of mediastinal neuroblastoma[J]. Eur J Pediatr Surg,2000,10(6):353-359.
[10] Calafiore L, Amoroso L, Della Casa Alberighi O, et al. Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma[J]. Ann Oncol, 2013,24(5): 1406-1413.
[11] Horiuchi A, Muraji T, Tsugawa C, et al. Thoracic neuroblastoma: outcome of incomplete resection[J]. Pediatr Surg Int,2004,20(9):714-718.
[12] Cruccetti A, Kiely EM, Spitz L, et al. Pelvic neuroblastoma: low mortality and high morbidity[J]. J Pediatr Surg,2000,35(5):724-728.
[13] Moukheiber AK, Nicollas R, Roman S, et al. Triglia JM. Primary pediatric neuroblastic tumors of the neck[J].Int J Pediatr Otorhinolaryngol,2001,60(2):155-161.
[14] Berdon WE, Stylianos S, Ruzal-Shapiro C, et al.M. Neuroblastoma arising from the organ of Zuckerkandl: an unusual site with a favorable biologic outcome[J].Pediatr Radiol,1999,29(7):497-502.

不同起源神经母细胞瘤N-myc基因扩增情况研究

A Study of the status of N-myc amplification in neuroblastoma originating from different sites

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 0

编辑推荐

Metrics

本文评价